Publicatielijst VUmc MS Centrum Amsterdam 2013 Doctoral Theses Bosma, L.V.A.E. (2013, April 19). Clinical outcome measures in progressive multiple sclerosis. VU University. Prom./coprom.: prof. dr. B.M.J. Uitdehaag & prof. dr. C.H. Polman. Doorn, R.P. van (2013, September 16). Harmony of Citizens is the Wall of Cities: orchestrating the neurovascular unit. VU University. Prom./coprom.: prof .dr. H.E. de Vries & prof. dr. C.D. Dijkstra. Kempen, J.C.E. (2013, march 21). Walking ability and daily functioning in Multiple Sclerosis. Prom./coprom.: prof. dr. G.J. Lankhorst, dr. H. Beckerman & dr. V. de Groot. Kooi, E.J. (2013, January 30). Grey matter pathology in multiple sclerosis. Histopathological, molecular biological and imaging studies. VU University. Prom./coprom.: prof. dr. P. van der Valk & prof. dr. J.J.G. Geurts. Mizee, M.R. (2013, September 13). Regulation of the blood-brain barrier in health and disease: Astrocytes at the barricade. VU University. Prom./coprom.: prof .dr. H.E. de Vries, prof. dr. C.D. Dijkstra & dr. ir. A. Reijerkerk. Sombekke, M.H. (2013, March 13). Genetic and Imaging Markers of Multiple Sclerosis Prognosis and Diagnosis. VU University. Prom./coprom.: prof. dr. C.H. Polman, prof. dr. F. Barkhof, prof. dr. J.J.G. Geurts & dr. ir. H. Vrenken. Scientific Publications (refereed) Balk, L.J. & Petzold, A. (2013). Influence of the Eye-Tracking-Based Follow-Up Function in Retinal Nerve Fiber Layer Thickness Using Fourier-Domain Optical Coherence Tomography. Investigative Ophthalmology and Visual Science, 54(4), 3045-3045. Balk, L.J., Mayer, M., Uitdehaag, B.M.J. & Petzold, A. (2013). Physiological variation of segmented OCT retinal layer thicknesses is short-lasting. Journal of Neurology, 260(12), 3109-3114. Barkhof, F. (2013). Efficient use of MRI for dose finding in multiple sclerosis. Lancet Neurology, 12(8), 730-731. Barkhof, F. & Wattjes, M.P. (2013). Multiple sclerosis: CCSVI deconstructed and discarded. Nature Reviews Neurology, 9, 661-662. Beckerman, H., Blikman, L.J.M., Heine, M., Malekzadeh, A., Teunissen, C.E., Bussmann, J.B.J., Kwakkel, G., Meeteren, J. van & Groot, V. de (2013). The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programme. Trials, 14, 250. Beckerman, H., Kempen, J.C.E., Knol, D.L., Polman, C.H., Lankhorst, G.J. & Groot, V. de (2013). The First 10 Years with Multiple Sclerosis: the Longitudinal Course of Daily Functioning. Journal of Rehabilitation Medicine, 45(1), 68-75. Benedict, R.H., Hulst, H.E., Bergsland, N., Schoonheim, M.M., Dwyer, M.G., Weinstock-Guttman, B., Geurts, J.J.G. & Zivadinov, R. (2013). Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients. Multiple Sclerosis, 19(11), 1478-1484. Bogie, J.F., Jorissen, W., Mailleux, J., Nijland, P.G., Zelcer, N., Vanmierlo, T., Horssen, J. van, Stinissen, P., Hellings, N. & Hendriks, JJ (2013). Myelin alters the inflammatory phenotype of macrophages by activating PPARs. Acta Neuropathologica Communinications, 1(1), 43. 1 Bosma, L.V.A.E., Kragt, J.J., Polman, C.H. & Uitdehaag, B.M.J. (2013). Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS. Multiple Sclerosis, 19(3), 326-333. Broek, C.M.A. Ten, Bots, J., Varela-Lasheras, I., Bugiani, M., Galis, F. & Dongen, S. Van (2013). Amniotic Fluid Deficiency and Congenital Abnormalities both Influence Fluctuating Asymmetry in Developing Limbs of Human Deceased Fetuses. PLoS One, 8(11), e81824. Bsibsi, M., Holtman, I.R., Gerritsen, W.H., Eggen, B.J.L., Boddeke, E., Valk, P. van der, Noort, J.M. van & Amor, S. (2013). Alpha-B-crystallin induces an immune-regulatory and antiviral microglial response in preactive multiple sclerosis lesions. Journal of Neuropathology and Experimental Neurology, 72(10), 970-979. Cohen, J.A., Barkhof, F., Comi, G., Izquierdo, G., Khatri, B., Montalban, X., Pelletier, J., Eckert, B., Haring, D.A. & Francis, G. (2013). Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS. Journal of Neurology, 260(8), 2023-2032. Daams, M., Geurts, J.J.G. & Barkhof, F. (2013). Cortical imaging in multiple sclerosis: recent findings and 'grand challenges'. Current Opinion in Neurology, 26(4), 345-352. Deddens, L.H., Tilborg, G.A.F. Van, Toorn, A. van der, Vries, H.E. de & Dijkhuizen, R.M. (2013). PECAM-1-targeted micron-sized particles of iron oxide as MRI contrast agent for detection of vascular remodeling after cerebral ischemia. Contrast media & molecular imaging, 8(5), 393-401. Delarasse, C., Smith, P., Baker, D. & Amor, S. (2013). Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice. Immunology, 140(4), 456-464. Derksen, A., Mokkink, L.B., Rietberg, M.B., Knol, D.L., Ostelo, R.W.J.G. & Uitdehaag, B.M.J. (2013). Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands. Quality of Life Research, 22(9), 2435-2441. Eijssen, I.C.J.M., Steultjens, M.P.M., Groot, V. de, Steultjens, E.M.J., Knol, D.L., Polman, C.H. & Dekker, J. (2013). A cluster randomised controlled trial on the efficacy of client-centred occupational therapy in multiple sclerosis: good process, poor outcome. Disability and Rehabilitation, 35(19), 16361646. Filippi, M., Rocca, M.A., Horsfield, M.A., Hametner, S., Geurts, J.J.G., Comi, G. & Lassmann, H. (2013). Imaging Cortical Damage and Dysfunction in Multiple Sclerosis. JAMA Neurology, 70(5), 556564. Giorgio, A., Battaglini, M., Rocca, M.A., Leucio, A. De, Absinta, M., Schijndel, R.A. van, Rovira, A., Tintore, M., Chard, D., Ciccarelli, O., Enzinger, C., Gasperini, C., Frederiksen, J., Filippi, M., Barkhof, F. & Stefano, N. De (2013). Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis. Neurology, 80(3), 234-241. Gnanapavan, S., Grant, D., Morant, S., Furby, J., Hayton, T., Teunissen, C.E., Leoni, V., Marta, M., Brenner, R., Palace, J., Miller, D. H., Kapoor, R. & Giovannoni, G. (2013). Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS - Neurofilament as a Surrogate of Disease Progression. PLoS One, 8(8), e70019. Graaf, W.L. de, Kilsdonk, I.D., Lopez Soriano, A., Zwanenburg, J.J.M., Visser, F., Polman, C.H., Castelijns, J.A., Geurts, J.J.G., Pouwels, P.J.W., Luijten, P.R., Barkhof, F. & Wattjes, M.P. (2013). Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter. European Radiology, 23(2), 528-540. 2 Hagemeier, J., Dwyer, M.G., Bergsland, N., Schweser, F., Magnano, C.R., Heininen-Brown, M., Ramasamy, D.P., Carl, E., Kennedy, C., Melia, R., Polak, P., Deistung, A., Geurts, J.J.G., Reichenbach, J.R. & Zivadinov, R. (2013). Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals. American Journal of Neuroradiology, 34(11), 2144-2151. Horssen, J. van & Vries, H.E. de (2013). Dimethyl fumarate: a novel oral front-line therapy for multiple sclerosis treatment. Future Neurology, 8(3), 247-254. Hulst, H.E., Steenwijk, M.D., Versteeg, A., Pouwels, P.J.W., Vrenken, H., Uitdehaag, B.M.J., Polman, C.H., Geurts, J.J.G. & Barkhof, F. (2013). Cognitive impairment in MS Impact of white matter integrity, gray matter volume, and lesions. Neurology, 80(11), 1025-1032. Inkster, B., Strijbis, E.M.M., Vounou, M., Kappos, L., Radue, E.W., Matthews, P.M., Uitdehaag, B.M.J., Barkhof, F., Polman, C.H., Montana, G. & Geurts, J.J.G. (2013). Histone deacetylase gene variants predict brain volume changes in multiple sclerosis. Neurobiology of Aging, 34(1), 238-247. Kappos, L., O'Connor, P.W., Polman, C.H., Vermersch, P., Wiendl, H., Pace, A., Zhang, A. & Hotermans, C. (2013). Clinical effects of natalizumab on multiple sclerosis appear early in treatment course. Journal of Neurology, 260(5), 1388-1395. Khalil, M., Enzinger, C., Langkammer, C., Ropele, S., Mader, A., Trentini, A., Vane, M.L.G., WallnerBlazek, M., Bachmaier, G., Archelos, J.J., Koel-Simmelink, M.J.A., Blankenstein, M.A., Fuchs, S., Fazekas, F. & Teunissen, C.E. (2013). CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome. Multiple Sclerosis, 19(4), 436-442. Kilsdonk, I.D., Graaf, W.L. de, Lopez Soriano, A., Zwanenburg, J.J., Visser, F., Kuijer, J.P.A., Geurts, J.J.G., Pouwels, P.J.W., Polman, C.H., Castelijns, J.A., Luijten, P.R., Barkhof, F. & Wattjes, M.P. (2013). Multicontrast MR imaging at 7T in multiple sclerosis: highest lesion detection in cortical gray matter with 3D-FLAIR. AJNR.American journal of neuroradiology, 34(4), 791-796. Klaver, R., Vries, H.E. de, Schenk, G.J. & Geurts, J.J.G. (2013). Grey matter damage in multiple sclerosis A pathology perspective. Prion, 7(1), 66-75. Koning, J.J., Kooij, G., Vries, H.E. de, Nolte, M.A. & Mebius, R.E. (2013). Mesenchymal stem cells are mobilized from the bone marrow during inflammation. Frontiers in Molecular Innate Immunity, 4, 49. Kremer, D., Schichel, T., Forster, M., Tzekova, N., Bernard, C., Valk, P. van der, Horssen, J. van, Hartung, H.P., Perron, H. & Kury, P. (2013). Human Endogenous Retrovirus Type W Envelope Protein Inhibits Oligodendroglial Precursor Cell Differentiation. Annals of Neurology, 74(5), 721-732. Kroksveen, A.C., Aasebo, E., Vethe, H., Pesch, V. van, Franciotta, D., Teunissen, C.E., Ulvik, R.J., Vedeler, C., Myhr, K.M., Barsnes, H. & Berven, F.S. (2013). Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM. Journal of Proteomics, 78, 312-325. Lukas, C., Sombekke, M.H., Bellenberg, B., Hahn, H.K., Popescu, V., Bendfeldt, K., Radue, E.W., Gass, A., Borgwardt, S.J., Kappos, L., Naegelin, Y., Knol, D.L., Polman, C.H., Geurts, J.J.G., Barkhof, F. & Vrenken, H. (2013). Relevance of Spinal Cord Abnormalities to Clinical Disability in Multiple Sclerosis: MR Imaging Findings in a Large Cohort of Patients. Radiology, 269(2), 541-551. Malekzadeh, A. & Teunissen, C. (2013). Recent progress in omics-driven analysis of MS to unravel pathological mechanisms. Expert Review of Neurotherapeutics, 13(9), 1001-1016. Meer, M.L. van der, Tewarie, P., Schoonheim, M.M., Douw, L., Barkhof, F., Polman, C.H., Stam, C.J. & Hillebrand, A. (2013). Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study. NeuroImage.Clinical, 2, 727-734. 3 Melief, J., Wit, S.J. de, Eden, C.G. van, Teunissen, C., Hamann, J., Uitdehaag, B.M.J., Swaab, D. & Huitinga, I. (2013). HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter. Acta Neuropathologica, 126(2), 237-249. Noort, J.M. van, Bsibsi, M., Nacken, P.J., Gerritsen, W.H., Amor, S., Holtman, I.R., Boddeke, E., Ark, I. van, Leusink-Muis, T., Folkerts, G., Hennink, W.E. & Amidi, M. (2013). Activation of an immuneregulatory macrophage response and inhibition of lung inflammation in a mouse model of COPD using heat-shock protein alpha B-crystallin-loaded PLGA microparticles. Biomaterials, 34(3), 831-839. Okuda, D.T. & Vrenken, H. (2013). Metabolite changes in radiologically isolated syndrome: more pathology than meets the eye? Neurology, 80(23), 2084-2085. Oosten, B.W. van, Killestein, J. & Wattjes, M.P. (2013). Case Reports of PML in Patients Treated for Psoriasis Reply. New England Journal of Medicine, 369(11), 1081-1082. Oosten, B.W. van, Killestein, J., Barkhof, F., Polman, C.H. & Wattjes, M.P. (2013). PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy. New England Journal of Medicine, 368(17), 1658-1659. Petzold, A., Islam, N., Hu, H.H. & Plant, G.T. (2013). Embolic and Nonembolic Transient Monocular Visual Field Loss: A Clinicopathologic Review. Survey of ophthalmology, 58(1), 42-62. Petzold, A. (2013). Intrathecal oligoclonal IgG synthesis in multiple sclerosis. Journal of Neuroimmunology, 262(1-2), 1-10. Petzold, A. (2013). Optic Neuritis: Another Dickensian Diagnosis. Neuro-ophthalmology, 37(6), 247250. Petzold, A., Islam, N. & Plant, G.T. (2013). Patterns of non-embolic transient monocular visual field loss. Journal of Neurology, 260(7), 1889-1900. Popescu, V., Agosta, F., Hulst, H.E., Sluimer, I.C., Knol, D.L., Sormani, M.P., Enzinger, C., Ropele, S., Alonso, J., Sastre-Garriga, J., Rovira, A., Montalban, X., Bodini, B., Ciccarelli, O., Khaleeli, Z., Chard, D.T., Matthews, L., Palace, J., Giorgio, A., Stefano, N. De, Eisele, P., Gass, A., Polman, C.H., Uitdehaag, B.M.J., Messina, M.J., Comi, G., Filippi, M., Barkhof, F. & Vrenken, H. (2013). Brain atrophy and lesion load predict long term disability in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 84(10), 1082-1091. Prins, M., Eriksson, C., Wierinckx, A., Bol, J.G.J.M., Binnekade, R., Tilders, F.J.H. & Dam, A.M. van (2013). Interleukin-1 beta and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis. PLoS One, 8(12), e83835. Puentes, F., Star, B.J. van der, Victor, M., Kipp, M., Beyer, C., Peferoen-Baert, R., Ummenthum, K., Pryce, G., Gerritsen, W.H., Huizinga, R., Reijerkerk, A., Valk, P. van der, Baker, D. & Amor, S. (2013). Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation, 10, 18. Reijerkerk, A., Lopez-Ramirez, M.A., Hof, B. van het, Drexhage, J.A.R., Kamphuis, W.W., Kooij, G., Vos, J.B., Pouw Kraan, C.T.M. van der, Zonneveld, A.J. van, Horrevoets, A.J., Prat, A., Romero, I.A. & Vries, H.E. de (2013). MicroRNAs Regulate Human Brain Endothelial Cell-Barrier Function in Inflammation: Implications for Multiple Sclerosis. Journal of Neuroscience, 33(16), 6857-6863. Rispens, T., Hart, M.H., Heer, P. Ooijevaar-de, Leeuwen, A. van, Vennegoor, A., Killestein, J., Wolbink, G.J. & Kleij, D. van der (2013). Drug interference in immunogenicity assays depends on valency. Journal of Pharmaceutical and Biomedical Analysis, 85, 179-185. 4 Rouwette, M., Noben, J.P., Horssen, J. van, Wijmeersch, B. Van, Hupperts, R., Jongen, P.J., Verbeek, M.M., Deyn, P.P. de, Stinissen, P. & Somers, V. (2013). Identification of coronin-1a as a novel antibody target for clinically isolated syndrome and multiple sclerosis. Journal of Neurochemistry, 126(4), 483-492. Rudick, R., Polman, C., Clifford, D., Miller, D. & Steinman, L. (2013). Natalizumab Bench to Bedside and Beyond. JAMA Neurology, 70(2), 172-182. Schenk, G.J., Dijkstra, S., Hof, A.J. van Het, Pol, S.M.A. van der, Drexhage, J.A.R., Valk, P. van der, Reijerkerk, A., Horssen, J. van & Vries, H.E. de (2013). Roles for HB-EGF and CD9 in multiple sclerosis. Glia, 61(11), 1890-1905. Schneider, E., Zimmermann, H., Oberwahrenbrock, T., Kaufhold, F., Kadas, E.M., Petzold, A., Bilger, F., Borisow, N., Jarius, S., Wildemann, B., Ruprecht, K., Brandt, A.U. & Paul, F. (2013). Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis. PLoS One, 8(6), e66151. Schoonheim, M.M., Geurts, J.J.G., Landi, D., Douw, L., Meer, M.L. van der, Vrenken, H., Polman, C.H., Barkhof, F. & Stam, C.J. (2013). Functional connectivity changes in multiple sclerosis patients: A graph analytical study of MEG resting state data. Human Brain Mapping, 34(1), 52-61. Singh, S., Metz, I., Amor, S., Valk, P. van der, Stadelmann, C. & Bruck, W. (2013). Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons. Acta Neuropathologica, 125(4), 595-608. Smolders, F., Moll, A.C. & Petzold, A. (2013). A smouldering fire in the eye: vuurtje. Journal of ophthalmic & vision research, 8(2), 190-190. Sombekke, M.H., Wattjes, M.P., Balk, L.J., Nielsen, J.M., Vrenken, H., Uitdehaag, B.M.J., Polman, C.H. & Barkhof, F. (2013). Spinal cord lesions in patients with clinically isolated syndrome A powerful tool in diagnosis and prognosis. Neurology, 80(1), 69-75. Sonder, J.M., Holman, R., Knol, D.L., Bosma, L.V.A.E., Polman, C.H. & Uitdehaag, B.M.J. (2013). Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosis. Journal of the Neurological Sciences, 334(1-2), 143-147. Stangel, M., Fredrikson, S., Meinl, E., Petzold, A., Stuve, O. & Tumani, H. (2013). The utility of cerebrospinal fluid analysis in patients with multiple sclerosis. Nature Reviews Neurology, 9(5), 267276. Steenwijk MD, Pouwels PJ, Daams M, van Dalen JW, Caan MW, Richard E, Barkhof F, Vrenken H. Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs). Neuroimage Clin. 2013 Oct 14;3:462-9. Stoffels, J.M.J., Jonge, J.C. de, Stancic, M., Nomden, A., Strien, M.E. van, Ma, D., Siskova, Z., Maier, O., Ffrench-Constant, C., Franklin, R.J.M., Hoekstra, D., Zhao, C. & Baron, W. (2013). Fibronectin aggregation in multiple sclerosis lesions impairs remyelination. Brain, 136, 116-131. Strijbis, E.M.M., Inkster, B., Vounou, M., Naegelin, Y., Kappos, L., Radue, E.W., Matthews, P.M., Uitdehaag, B.M.J., Barkhof, F., Polman, C.H., Montana, G. & Geurts, J.J.G. (2013). Glutamate gene polymorphisms predict brain volumes in multiple sclerosis. Multiple Sclerosis, 19(3), 281-288. Teunissen, C., Menge, T., Altintas, A., Alvarez-Cermeno, J.C., Bertolotto, A., Berven, F.S., Brundin, L., Comabella, M., Degn, M., Deisenhammer, F., Fazekas, F., Franciotta, D., Frederiksen, J.L., Galimberti, D., Gnanapavan, S., Hegen, H., Hemmer, B., Hintzen, R., Hughes, S., Iacobaeus, E., Kroksveen, A.C., Kuhle, J., Richert, J., Tumani, H., Villar, L.M., Drulovic, J., Dujmovic, I., Khalil, M. & Bartos, A. (2013). Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Multiple Sclerosis, 19(13), 1802-1809. 5 Tewarie, P., Schoonheim, M.M., Stam, C.J., Meer, M.L. van der, Dijk, B.W. van, Barkhof, F., Polman, C.H. & Hillebrand, A. (2013). Cognitive and Clinical Dysfunction, Altered MEG Resting-State Networks and Thalamic Atrophy in Multiple Sclerosis. PLoS One, 8(7), e69318. Tossberg, J.T., Crooke, P.S., Henderson, M.A., Sriram, S., Mrelashvili, D., Vosslamber, S., Verweij, C.L., Olsen, N.J. & Aune, T.M. (2013). Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis. Bioinformatics, 3, 18. Valdueza, J.M., Doepp, F., Schreiber, S.J., Oosten, B.W. van, Schmierer, K., Paul, F. & Wattjes, M.P. (2013). What went wrong? The flawed concept of cerebrospinal venous insufficiency. Journal of Cerebral Blood Flow and Metabolism, 33(5), 657-668. Vennegoor, A., Rispens, T., Strijbis, E.M.M., Seewann, A., Uitdehaag, B.M.J., Balk, L.J., Barkhof, F., Polman, C.H., Wolbink, G. & Killestein, J. (2013). Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis. Multiple Sclerosis, 19(5), 593-600. Verweij, C.L. & Vosslamber, S. (2013). Relevance of the Type I Interferon Signature in Multiple Sclerosis Towards a Personalized Medicine Approach for Interferon-beta Therapy. Discovery Medicine, 80, 51-60. Vogel, D.Y.S., Vereyken, E.J.F., Glim, J.E., Heijnen, D.A.M., Moeton, M., Valk, P. van der, Amor, S., Teunissen, C.E., Horssen, J. van & Dijkstra, C.D. (2013). Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. Journal of Neuroinflammation, 10, 35. Vrenken, H., Jenkinson, M., Horsfield, M.A., Battaglini, M., Schijndel, R.A. van, Rostrup, E., Geurts, J.J.G., Fisher, E., Zijdenbos, A., Ashburner, J., Miller, D. H., Filippi, M., Fazekas, F., Rovaris, M., Rovira, A., Barkhof, F. & Stefano, N. De (2013). Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. Journal of Neurology, 260(10), 2458-2471. Wallner-Blazek, M., Rovira, A., Fillipp, M., Rocca, M.A., Miller, D. H., Schmierer, K., Frederiksen, J., Gass, A., Gama, H., Tilbery, C.P., Rocha, A.J. Da, Flores, J., Barkhof, F., Seewann, A., Palace, J., Yousry, T., Montalban, X., Enzinger, C. & Fazekas, F. (2013). Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis. Journal of Neurology, 260(8), 2016-2022. Wattjes, M.P., Verhoeff, L., Zentjens, W., Killestein, J., Munster, E.T. van, Barkhof, F. & Eijk, J.J.J. van (2013). Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumabassociated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation? Journal of Neurology, Neurosurgery and Psychiatry, 84(10), 1176-1177. Wattjes, M.P., Richert, N.D., Killestein, J., Vos, M., Sanchez, E., Snæbjörnsson, P., Cadavid, D. & Barkhof, F. (2013). The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. Multiple Sclerosis, 19(14), 1826-1840. Weemaes, C.M.R., Tol, M.J.D. van, Wang, J., Dam, M., Eggermond, M.C.J.A. van, Thijssen, P.E., Aytekin, C., Brunetti-Pierri, N., Burg, M. van der, Davies, E. Graham, Ferster, A., Furthner, D., Gimelli, G., Gennery, A., Kloeckener-Gruissem, B., Meyn, S., Powell, C., Reisli, I., Schuetz, C., Schulz, A., Shugar, A., Elsen, P.J. van den & Maarel, S.M. van der (2013). Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects. European Journal of Human Genetics, 21(11), 1219-1225. Witte, M.E., Nijland, P.G., Drexhage, J.A.R., Gerritsen, W.H., Geerts, D., Hof, B.V., Reijerkerk, A., Vries, H.E. de, Valk, P. van der & Horssen, J. van (2013). Reduced expression of PGC-1 alpha partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathologica, 125(2), 231-243. 6 Young, K.L., Brandt, A.U., Petzold, A., Reitz, L.Y., Lintze, F., Paul, F., Martin, R. & Schippling, S. (2013). Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis. European Journal of Neurology, 20(5), 803-811. Scientific Publications (non-refereed) Poon, K.W., Brideau, C., Teo, W., Schenk, G.J., Klaver, R., Klauser, A.M., Kawasoe, J., Geurts, J.J.G. & Stys, P.K. (2013). Investigation of human multiple sclerosis lesions using high resolution spectrally unmixed CARS microscopy. Proceedings of SPIE - International Society for Optical Engineering, 8565. Scientific Publications Books Amor, S. & Noort, H. van (2013). Multiple Sclerosis. Oxford, UK: Oxford University Press (ISBN 9780199652570). Wattjes, M.P. & Fischer, D. (2013). Neuromuscular imaging. New York: Springer (ISBN 978-1-46146551-5). Book Chapters Noort, J.M. van & Amor, S. (2013). Pathophysiology of multiple sclerosis: a controversial new perspective. In Personalized Management of Multiple Sclerosis (pp. 22-34). Quijano-Roy, S., Avila-Smirnow, D., Carlier, R.Y., Wattjes, M.P. & Fischer, D. (2013). Motor Neuron Diseases. In M.P. Wattjes & D. Fischer (Eds.), Neuromuscular Imaging (pp. 375-388) (ISBN 978-14614-6551-5). Verweij, C.L. & Vosslamber, S. (2013). The interferon system in multiple sclerosis; Towards a personalized medicine approach for IFNBeta therapy. In Y. Yao (Ed.), Type I interferon in autoimmune diseases and its clinical applications (pp. 9). Nova Biomedical Publishers. Wattjes, M.P. (2013). Computed Tomography. In M.P. Wattjes & D. Fischer (Eds.), Neuromuscular Imaging (pp. 23-26) (ISBN 978-1-4614-6551-5). Wattjes, M.P. (2013). Conventional Magnetic Resonance Imaging. In M.P. Wattjes & D. Fischer (Eds.), Neuromuscular Imaging (pp. 27-34) (ISBN 978-1-4614-6551-5). Wattjes, M.P. (2013). Dementing Disorders. In G. Guiglielmi, W.C.G. Peh & A. Guermazi (Eds.), Geriatric Imaging (pp. 641-674) (ISBN 978-3-642-35578-3). Wattjes, M.P. & Fischer, D. (2013). Normal Aging Muscle Tissue. In M.P. Wattjes & D. Fischer (Eds.), Neuromuscular Imaging (pp. 101-107) (ISBN 978-1-4614-6551-5). Wattjes, M.P. (2013). Nuclear Medicine Methods. In M.P. Wattjes & D. Fischer (Eds.), Neuromuscular Imaging (pp. 55-61) (ISBN 978-1-4614-6551-5). Other Output Inaugural Addresses Geurts, J.J.G. (2013). Een brede blik op het brein (2013, March 19). Amsterdam: Vrije Universiteit. 7
© Copyright 2024 ExpyDoc